Andreas Pettersson

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2023;32(10):1436-1443
Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study
Ma C; Wang X; Dai JY; Turman C; Kraft P; Stopsack KH; Loda M; Pettersson A; Mucci LA; Stanford JL; Penney KL
Article: BRITISH JOURNAL OF CANCER. 2023;128(12):2261-2269
Risk and mortality of testicular cancer in patients with neurodevelopmental or other psychiatric disorders
Jansson AK; Soderling J; Reutfors J; Thor A; Skold C; Cohn-Cedermark G; Stahl O; Smedby KEE; Pettersson A; Glimelius I
Article: MOLECULAR CANCER RESEARCH. 2023;21(1):14-23
Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions
Stopsack KH; Su XA; Vaselkiv JB; Graff RE; Ebot EM; Pettersson A; Lis RT; Fiorentino M; Loda M; Penney KL; Lotan TL; Mucci LA
Article: FRONTIERS IN ONCOLOGY. 2023;13:1242639
Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort
Destefanis N; Fiano V; Milani L; Vasapolli P; Fiorentino M; Giunchi F; Lianas L; Del Rio M; Frexia F; Pireddu L; Molinaro L; Cassoni P; Papotti MG; Gontero P; Calleris G; Oderda M; Ricardi U; Iorio GC; Fariselli P; Isaevska E; Akre O; Zelic R; Pettersson A; Zugna D; Richiardi L
Article: CANCER PREVENTION RESEARCH. 2022;15(12):815-825
Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different?
Zhou CD; Pettersson A; Plym A; Tyekucheva S; Penney KL; Sesso HD; Kantoff PW; Mucci LA; Stopsack KH
Article: CLINICAL EPIDEMIOLOGY. 2022;14:59-70
Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade
Zelic R; Giunchi F; Fridfeldt J; Carlsson J; Davidsson S; Lianas L; Mascia C; Zugna D; Molinaro L; Vincent PH; Zanetti G; Andren O; Richiardi L; Akre O; Fiorentino M; Pettersson A
Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2021;110(6):1613-1621
Replication of Oncology Randomized Trial Results using Swedish Registry Real World-Data: A Feasibility Study
Jemielita T; Widman L; Fox C; Salomonsson S; Liaw K-L; Pettersson A
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2021;55(4):299-306
Real world treatment utilization patterns in patients with castration-resistant prostate cancer
Vigneswaran HT; Warnqvist A; Andersson TML; Leval A; Eklund M; Nordstrom T; Eloranta S; Schain F; Dearden L; Liwing J; Mehra M; Nair S; Pettersson A; Akre O; Aly M
Article: SCIENTIFIC REPORTS. 2021;11(1):3257
Interchangeability of light and virtual microscopy for histopathological evaluation of prostate cancer
Zelic R; Giunchi F; Lianas L; Mascia C; Zanetti G; Andren O; Fridfeldt J; Carlsson J; Davidsson S; Molinaro L; Vincent PH; Richiardi L; Akre O; Fiorentino M; Pettersson A
Article: JNCI CANCER SPECTRUM. 2021;5(1):pkaa084-
Long-Term Prognostication for 20 114 Women With Small and Node-Negative Breast Cancer (T1abN0)
Jaraj D; Hoijer J; Widman L; Ahlgren J; Arnesson L-G; Einbeigi Z; Klintman M; Patil EV; Sund M; Fredriksson I; Bergh J; Andreas P
Article: CARCINOGENESIS. 2020;41(7):904-908
Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer
Stopsack KH; Gerke T; Zareba P; Pettersson A; Chowdhury D; Ebot EM; Flavin R; Finn S; Kantoff PW; Stampfer MJ; Loda M; Fiorentino M; Mucci LA
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;146(10):2694-2702
Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer
Hashim D; Gonzalez-Feliciano AG; Ahearn TU; Pettersson A; Barber L; Pernar CH; Ebot EM; Isikbay M; Finn SP; Giovannucci EL; Lis RT; Loda M; Parmigiani G; Lotan T; Kantoff PW; Mucci LA; Graff RE
Article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):581-586
Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors
Wadstrom H; Pettersson A; Smedby KE; Askling J
Article: ACTA ONCOLOGICA. 2020;59(4):388-394
Treatment patterns and survival outcomes for small-cell lung cancer patients - a Swedish single center cohort study
Tendler S; Zhan Y; Pettersson A; Lewensohn R; Viktorsson K; Fang F; De Petris L
Article: JNCI CANCER SPECTRUM. 2020;4(2):pkaa006
Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort Study
Pettersson A; Alm D; Garmo H; Eriksson MH; Castellanos E; Astrom L; Kindblom J; Widmark A; Gunnlaugsson A; Lissbrant IF; Nilsson P; Stattin P
Article: EUROPEAN UROLOGY. 2020;77(2):180-188
Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study
Zelic R; Garmo H; Zugna D; Stattin P; Richiardi L; Akre O; Pettersson A
Article: CLINICAL EPIGENETICS. 2019;11(1):152
DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancer
Fiano V; Zugna D; Grasso C; Trevisan M; Delsedime L; Molinaro L; Cassoni P; Papotti M; Merletti F; Akre O; Pettersson A; De Marco L; Richiardi L
Article: WORLD JOURNAL OF SURGERY. 2019;43(9):2262-2270
Bilateral Risk-Reducing Mastectomies with Implant-Based Reconstructions Followed Long Term: A Consecutive Series of 185 Patients
Isaksson K; Arver B; Bottai M; Pettersson A; Wickman M; Sandelin K
Article: EUROPEAN UROLOGY. 2019;76(1):33-40
A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG
Pernar CH; Ebot EM; Pettersson A; Graff RE; Giunchi F; Ahearn TU; Gonzalez-Feliciano AG; Markt SC; Wilson KM; Stopsack KH; Gazeeva E; Lis RT; Parmigiani G; Rimm EB; Finn SP; Giovannucci EL; Fiorentino M; Mucci LA
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2019;188(6):1165-1173
Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study
Zelic R; Zugna D; Bottai M; Andren O; Fridfeldt J; Carlsson J; Davidsson S; Fiano V; Fiorentino M; Giunchi F; Grasso C; Lianas L; Mascia C; Molinaro L; Zanetti G; Richiardi L; Pettersson A; Akre O
Article: CARCINOGENESIS. 2018;39(12):1431-1437
Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease
Ahearn TU; Peisch S; Pettersson A; Ebot EM; Zhou CK; Graff RE; Sinnott JA; Fazli L; Judson GL; Bismar TA; Rider JR; Gerke T; Chan JM; Fiorentino M; Flavin R; Sesso HD; Finn S; Giovannucci EL; Gleave M; Loda M; Li Z; Pollak M; Mucci LA
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2018;18(1):161
Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies
Carlsson J; Davidsson S; Fridfeldt J; Giunchi F; Fiano V; Grasso C; Zelic R; Richiardi L; Andren O; Pettersson A; Fiorentino M; Akre O
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2018;52(5-6):313-320
SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
Stranne J; Brasso K; Brennhovd B; Johansson E; Jaderling F; Kouri M; Lilleby W; Petersen PM; Mirtti T; Pettersson A; Rannikko A; Thellenberg C; Akre O
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2018;27(10):1231-1233
A Prospective Study of Aspirin Use and Prostate Cancer Risk by TMPRSS2:ERG Status
Stopsack KH; Gonzalez-Feliciano AG; Peisch SF; Downer MK; Gage RA; Finn S; Lis RT; Graff RE; Pettersson A; Pernar CH; Loda M; Kantoff PW; Ahearn TU; Mucci LA
Article: EUROPEAN UROLOGY. 2018;73(4):502-511
Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study
Robinson D; Garmo H; Lissbrant IF; Widmark A; Pettersson A; Gunnlaugsson A; Adolfsson J; Bratt O; Nilsson P; Stattin P
Article: ANNALS OF ONCOLOGY. 2018;29(2):377-385
Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study
Pettersson A; Robinson D; Garmo H; Holmberg L; Stattin P
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2018;27(2):193-200
Height, Obesity, and the Risk of TMPRSS2: ERG-Defined Prostate Cancer
Graff RE; Ahearn TU; Pettersson A; Ebot EM; Gerke T; Penney KL; Wilson KM; Markt SC; Pernar CH; Gonzalez-Feliciano AG; Song M; Lis RT; Schmidt DR; Vander Heiden MG; Fiorentino M; Giovannucci EL; Loda M; Mucci LA
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2018;27(2):201-207
MYC Overexpression at the Protein and mRNA Level and Cancer Outcomes among Men Treated with Radical Prostatectomy for Prostate Cancer
Pettersson A; Gerke T; Penney KL; Lis RT; Stack EC; Pertega-Gomes N; Zadra G; Tyekucheva S; Giovannucci EL; Mucci LA; Loda M
Article: PROSTATE. 2017;77(6):647-653
Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG
Graff RE; Judson G; Ahearn TU; Fiorentino M; Loda M; Giovannucci EL; Mucci LA; Pettersson A
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2017;26(5):719-726
Perineural Invasion and Risk of Lethal Prostate Cancer.
Zareba P; Flavin R; Isikbay M; Rider JR; Gerke TA; Finn S; Pettersson A; Giunchi F; Unger RH; Tinianow AM; Andersson S-O; Andrén O; Fall K; Fiorentino M; Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToP
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2016;25(5):745-749
Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes
Penney KL; Pettersson A; Shui IM; Graff RE; Kraft P; Lis RT; Sesso HD; Loda M; Mucci LA
Article: BRITISH JOURNAL OF CANCER. 2016;114(8):939-944
Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression
Graff RE; Meisner A; Ahearn TU; Fiorentino M; Loda M; Giovannucci EL; Mucci LA; Pettersson A
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2016;103(3):851-860
Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression
Graff RE; Pettersson A; Lis RT; Ahearn TU; Markt SC; Wilson KM; Rider JR; Fiorentino M; Finn S; Kenfield SA; Loda M; Giovannucci EL; Rosner B; Mucci LA
Article: CLINICAL CANCER RESEARCH. 2016;22(4):984-992
Global Hypomethylation (LINE-1) and Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate Biopsy as Markers of Prostate Cancer on a Rebiopsy
Zelic R; Fiano V; Zugna D; Grasso C; Delsedime L; Daniele L; Galliano D; Pettersson A; Gillio-Tos A; Merletti F; Richiardi L
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2016;108(2):djv346
A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer
Ahearn TU; Pettersson A; Ebot EM; Gerke T; Graff RE; Morais CL; Hicks JL; Wilson KM; Rider JR; Sesso HD; Fiorentino M; Flavin R; Finn S; Giovannucci EL; Loda M; Stampfer MJ; De Marzo AM; Mucci LA; Lotan TL
Article: CANCER & METABOLISM. 2016;4:22
The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study.
Kelly RS; Sinnott JA; Rider JR; Ebot EM; Gerke T; Bowden M; Pettersson A; Loda M; Sesso HD; Kantoff PW; Martin NE; Giovannucci EL; Tyekucheva S; Heiden MV; Mucci LA
Article: BRITISH JOURNAL OF CANCER. 2015;113(7):1104-1113
Postmenopausal mammographic breast density and subsequent breast cancer risk according to selected tissue markers
Yaghjyan L; Pettersson A; Colditz GA; Collins LC; Schnitt SJ; Beck AH; Rosner B; Vachon C; Tamimi RM
Article: PROSTATE. 2015;75(9):897-906
The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.
Graff RE; Pettersson A; Lis RT; DuPre N; Jordahl KM; Nuttall E; Rider JR; Fiorentino M; Sesso HD; Kenfield SA; Loda M; Giovannucci EL; Rosner B; Nguyen PL; Sweeney CJ; Mucci LA; Transdisciplinary Prostate Cancer Partnership ToPC
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2015;18(1):1-12
Global DNA hypomethylation in prostate cancer development and progression: a systematic review
Zelic R; Fiano V; Grasso C; Zugna D; Pettersson A; Gillio-Tos A; Merletti F; Richiardi L
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2014;23(10):2027-2031
Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer.
Yoo S; Pettersson A; Jordahl KM; Lis RT; Lindstrom S; Meisner A; Nuttall EJ; Stack EC; Stampfer MJ; Kraft P; Brown M; Loda M; Giovannucci EL; Kantoff PW; Mucci LA
Article: CLINICAL CANCER RESEARCH. 2014;20(18):4904-4911
SPINK1 protein expression and prostate cancer progression.
Flavin R; Pettersson A; Hendrickson WK; Fiorentino M; Finn S; Kunz L; Judson GL; Lis R; Bailey D; Fiore C; Nuttall E; Martin NE; Stack E; Penney KL; Rider JR; Sinnott J; Sweeney C; Sesso HD; Fall K; Giovannucci E; Kantoff P; Stampfer M; Loda M; Mucci LA
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2013;105(24):1881-1890
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.
Pettersson A; Lis RT; Meisner A; Flavin R; Stack EC; Fiorentino M; Finn S; Graff RE; Penney KL; Rider JR; Nuttall EJ; Martin NE; Sesso HD; Pollak M; Stampfer MJ; Kantoff PW; Giovannucci EL; Loda M; Mucci LA
Article: LAKARTIDNINGEN. 2013;110(9-10):470-474
[Biostatistics has a central role in epidemiology. Introduction to concepts and methods from clinical observational studies].
Pettersson A
Article: LAKARTIDNINGEN. 2013;110(7):334-337
[Studying rare outcomes].
Reutfors J; Olén O; Magnusson C; Pettersson A
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2012;21(9):1497-1509
The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.
Pettersson A; Graff RE; Bauer SR; Pitt MJ; Lis RT; Stack EC; Martin NE; Kunz L; Penney KL; Ligon AH; Suppan C; Flavin R; Sesso HD; Rider JR; Sweeney C; Stampfer MJ; Fiorentino M; Kantoff PW; Sanda MG; Giovannucci EL; Ding EL; Loda M; Mucci LA
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2012;21(3):428-436
Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death.
Pettersson A; Kasperzyk JL; Kenfield SA; Richman EL; Chan JM; Willett WC; Stampfer MJ; Mucci LA; Giovannucci EL
Article: CANCER EPIDEMIOLOGY. 2011;35(6):e100-e104
Perinatal risk factors for childhood testicular germ-cell cancer: A Nordic population-based study
Stephansson O; Wahnstrom C; Pettersson A; Sorensen HT; Tretli S; Gissler M; Troisi R; Akre O; Grotmol T
Article: BREAST CANCER RESEARCH. 2011;13(5):R100
Nondense mammographic area and risk of breast cancer.
Pettersson A; Hankinson SE; Willett WC; Lagiou P; Trichopoulos D; Tamimi RM
Article: JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH. 2011;65(2):119-123
Differences in citation rates by country of origin for papers published in top-ranked medical journals: do they reflect inequalities in access to publication?
Akre O; Barone-Adesi F; Pettersson A; Pearce N; Merletti F; Richiardi L
Article: PLOS ONE. 2010;5(12):e14285
Cancer Risk in Mothers of Men Operated for Undescended Testis
Lacerda HM; Richiardi L; Pettersson A; Corbin M; Merletti F; Akre O
Article: INTERNATIONAL JOURNAL OF ANDROLOGY. 2009;32(5):473-478
Rates of orchiopexies in Sweden: 1977-1991
Richiardi L; Vizzini L; Nordenskjold A; Pettersson A; Akre O
Article: INTERNATIONAL JOURNAL OF CANCER. 2009;124(3):687-689
Risk of contralateral testicular cancer among men with unilaterally undescended testis: A meta analysis
Akre O; Pettersson A; Richiardi L
Article: CANCER RESEARCH. 2008;68(21):8832-8836
Gestational Hypertension, Preeclampsia, and Risk of Testicular Cancer
Pettersson A; Richiardi L; Cnattingius S; Kaijser M; Akre O
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2007;356(18):1835-1841
Age at surgery for undescended testis and risk of testicular cancer
Pettersson A; Richiardi L; Nordenskjold A; Kaijser M; Akre O
Article: INTERNATIONAL JOURNAL OF CANCER. 2007;120(9):2044-2046
Maternal smoking and the epidemic of testicular cancer - A nested case-control study
Pettersson A; Akre O; Richiardi L; Ekbom A; Kaijser M
Article: INTERNATIONAL JOURNAL OF CANCER. 2004;109(6):941-944
Women smoking and testicular cancer: One epidemic causing another?
Pettersson A; Kaijser M; Richiardi L; Askling J; Ekbom A; Akre O
Visa fler

Alla övriga publikationer

Corrigendum: EUROPEAN UROLOGY. 2020;78(1):e45-e47
Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study (vol 77, pg 180, 2020)
Zelic R; Garmo H; Zugna D; Stattin P; Richiardi L; Akre O; Pettersson A
Letter: ANNALS OF ONCOLOGY. 2018;29(9):2020-2021
Reply to the letter to the editor 'Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies' by X. Dong, G. Ma and F. Chen
Pettersson A; Robinson D; Garmo H; Holmberg L; Stattin P
Review: CANCER. 2017;123(9):1490-1496
The ABC model of prostate cancer: A conceptual framework for the design and interpretation of prognostic studies
Pettersson A; Gerke T; Fall K; Pawitan Y; Holmberg L; Giovannucci EL; Kantoff PW; Adami H-O; Rider JR; Mucci LA
Review: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2014;106(5):dju078
Mammographic Density Phenotypes and Risk of Breast Cancer: A Meta-analysis
Pettersson A; Graff RE; Ursin G; Silva IDS; McCormack V; Baglietto L; Vachon C; Bakker MF; Giles GG; Chia KS; Czene K; Eriksson L; Hall P; Hartman M; Warren RML; Hislop G; Chiarelli AM; Hopper JL; Krishnan K; Li J; Li Q; Pagano I; Rosner BA; Wong CS; Scott C; Stone J; Maskarinec G; Boyd NF; van Gils CH; Tamimi RM
Letter: BREAST CANCER RESEARCH AND TREATMENT. 2012;135(1):321-323
Breast fat and breast cancer.
Pettersson A; Tamimi RM
Corrigendum: CANCER EPIDEMIOLOGY. 2012;36(3):327
Perinatal risk factors for childhood testicular germ-cell cancer: A Nordic population-based study (vol 35, pg E100, 2011)
Stephansson O; Wahnstrom C; Pettersson A; Sorensen HT; Tretli S; Gissler M; Troisi R; Akre O; Grotmol T
Thesis / dissertation: 2008
Testicular cancer : new etiological understanding of the epidemic
Pettersson, Andreas
Published conference paper: INTERNATIONAL JOURNAL OF ANDROLOGY. 2007;30(4):230-240
Genetic and environmental risk factors for testicular cancer
Richiardi L; Pettersson A; Akre O
Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2007;357(8):826-827
Correction of cryptorchidism and testicular cancer - Reply
Pettersson A; Akre O; Richiardi L

Anställningar

Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2023-2025

Examina och utbildning

Docent, klinisk epidemiologi, Karolinska Institutet, 2018
Medicine Doktorsexamen, Institutionen för medicin, Solna, Karolinska Institutet, 2008
Läkarexamen, Karolinska Institutet, 2007

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI